CHAPTER 3: THE EU ALCOHOL STRATEGY 2006-12
Background
54. In June 2001 the Council invited the European
Commission to propose an EU strategy to complement national policies,
aimed at reducing alcohol-related harm.[45]
Five years later, in October 2006, the Commission proposed and
the Council adopted the first EU Alcohol Strategy with a Communication
on 'An EU strategy to support Member States in reducing alcohol
related harm'. The Strategy identified five priority themes under
which action was to be taken to address the adverse health effects
related to harmful and hazardous alcohol consumption in the EU. Box
5: Priorities of the EU Alcohol Strategy 2006-12
· Protecting young people, children and the unborn child
· Reducing injuries and death from alcohol-related road accidents
· Reducing alcohol-related harm among adults, including in the workplace
· Increasing information, education and awareness raising
· Developing and maintaining a common evidence base
|
55. Within each of these themes, the Strategy
identified the rationale and aims for action, as well as highlighting
cases of good practice. It noted the different contexts in which
national alcohol strategies operate and stressed the importance
of local action. It also set out a 'health in all policies' approach
by emphasising that "EU competence in health is not confined
to specific public health actions. Where possible, the Commission
will seek to improve the coherence between policies that have
an impact on alcohol-related harm". The merits of this approach
are examined in Chapter 5.
56. Given the EU's limited competence in the
field of public health,[46]
the Commission took on a mainly coordinating role. In order to
support Member States in implementing the Strategy, a European
Alcohol and Health Forum (EAHF) and a Committee on National Alcohol
Policy and Action (CNAPA) were established in 2007.
57. The EAHF is a platform where bodies such
as European NGOs and trade associations can debate and commit
themselves to actions intended to tackle alcohol-related harm.
[47] CNAPA is composed
of national delegates appointed by the Member States. Its main
objectives are "sharing good practices and aiming to achieve
the broadest possible consensus and convergence of alcohol policies
within the EU".[48]
Unlike the EAHF, CNAPA is not referred to in the Strategy. The
structure and functioning of both bodies is discussed in more
detail in Chapter 8.
58. The Commission further allocated funding
to a wide range of projects and research on alcohol-related harm,
which was provided through the EU's health and research programmes.
A list of projects on alcohol funded since 2003 is available on
the Commission's public health website.[49]
We consider this further in Chapter 9.
59. In 2012 DG SANCO commissioned an evaluation
of the Strategy and its added value,[50]
which found that several Member States introduced or strengthened
national alcohol strategies between 2006 and 2012, and that the
Strategy's five priorities remained relevant. The evaluation was
criticised by the Commission's Unit for Evaluation for failing
to establish a causal relationship between these developments
and the implementation of the Strategy, and for describing "outputs
rather than outcomes". This was in a sense inevitable, as
the Strategy had no inbuilt evaluation mechanism and did not include
quantitative targets, a problem to which we refer below in paragraphs
64-66. Nonetheless many of our witnesses, including the Government,
endorsed the 2012 evaluation and regarded it as confirmation that
the Strategy had generally been useful and should continue in
some form, albeit taking into account their numerous suggested
modifications.[51]
Impact on the United Kingdom
60. We were told of no concrete benefits to the
UK in terms of reduction in alcohol consumption or alcohol-related
harm which could specifically be attributed to the Strategy, and
witnesses could not identify any particular national policy approach
which might have been influenced by the Strategy.[52]
However, there was a feeling among witnesses that this was due
to the pre-existing high standards of UK alcohol policies.
61. Ms Ellison, for instance, stated that
"I have not seen a huge impact on us, but I think that is
because we probably took alcohol policy and the enforcement of
various aspects of alcohol policy pretty seriously."[53]
Nonetheless, she regarded the Strategy as a useful point of reference
for the UK, in that it constituted an international agreement
which the Government was keen to observe and "report against".[54]
62. Furthermore, Miles Beale, Chief Executive
of the Wine and Spirits Trade Association, was of the opinion
that through the Strategy, the UK had been able to positively
influence other Member States: "[the Strategy] is more useful
to countries other than the UK, because
the UK has made
great progress and those ideas have been picked up disproportionately
elsewhere."[55]
Key achievements and shortcomings
63. When asked to assess whether the Strategy
had met its overall objective of reducing alcohol-related harm
in the EU, many witnesses highlighted the difficulty of attributing
outcomes accurately to any one policy measure or strategy. The
complexity of policy-making and the many cultural, economic and
social differences between Member States to which we have referred
in the previous chapter, mean that it is rarely possible to establish
a clear causal connection between a particular measure and increases
or decreases in the level of alcohol-related harm.[56]
64. This problem is exacerbated by the lack of
indicators, standardised data collection systems or an evaluation
mechanism by which it would have been possible to assess whether
or not the Strategy had achieved its objective. Eric Carlin, the
Director of the NGO Scottish Health Action on Alcohol Problems
(SHAAP), noted that, in the absence of SMART targets,[57]
it was difficult to assess what would have been achieved had the
Strategy not been in place.[58]
This problem was also acknowledged by the 2012 evaluation of the
Strategy, which stated that "as there is limited availability
of timely EU-wide data, evidence of the added value of EU level
action may only become available in the long term".
65. Prof Anderson was therefore critical
of the Strategy's overall effect, stating that "there is
little evidence that it has had any impact in reducing alcohol-related
harm in Europe
There is no doubt the Strategy made a lot
of noise and brought a lot of people together, but if you judge
it in terms of whether or not it has had an impact in reducing
harm, which was its main goal, one would have to say that it has
not achieved that."[59]
Professor Petra Meier from the University of Sheffield supported
this view, adding that: "What the Strategy lacked was a clear
focus on how to achieve change. It said it would do all sorts
of things, but there was nothing in there that was clear, action-focused
messaging."[60]
66. Other witnesses were more positive, and felt
that despite not meeting its broad aims, the Strategy had been
useful in general and also in some specific respects. Many felt
that it had focused the discussion on alcohol-related harm, and
Mr Carlin said: "The fact that the alcohol Strategy
exists keeps in the public profile that alcohol harm remains significant
Just its very existence makes a statement that has an impact."[61]
67. Glenis Willmott MEP, a member of the
European Parliament's Environment, Public Health and Food Safety
Committee (ENVI), thought that the Strategy had provided an important
impetus for action in several Member States: "More countries
now have national alcohol strategies in place. Ten countries adopted
or revised a national strategy after 2006, so that has to be seen
as a positive thing
All Member States do awareness-raising
activities that they would not have done in the past."[62]
The industry representative body spiritsEUROPE agreed, writing
that: "The Strategy has offered a stimulus to action and
has pushed stakeholders towards meaningful action to reduce alcohol-related
harm."[63]
68. Many witnesses suggested that the Strategy's
key achievement was its ability to facilitate the exchange of
best practices through CNAPA and the EAHF.[64]
Ms Skar noted that in this way, the Strategy "has increased
partnerships and networking across Europe".[65]
Representatives of the alcohol and advertising industries were
particularly eager to maintain the 'multi-stakeholder approach'
introduced through the EAHF, which was seen as an "effective
way of exchanging good practice",[66]
and described by Mr Ashworth, Chief Executive of the Portman
Group, as "very valuable".[67]
This approach has not been without difficulties, as we explain
in Chapter 8.
69. There was consensus among witnesses that
the Strategy had been more successful in some of its five priority
areas than others. Crispin Acton, Programme Manager for Alcohol
Misuse at the Department of Health, referred to the 2012 evaluation
of the Strategy to describe steps taken under its first priority
area: "There have been quite a lot of moves towards greater
commonality on underage purchasing, so there is much more similarity
in the age levels for underage purchasing and improved enforcement."[68]
70. Ms Ellison and Mr Acton also mentioned
a reduction in drink driving incidents as a specific area in which
the Strategy had influenced and improved action across the EU.[69]
In this regard Katherine Brown, the Director of the Institute
of Alcohol Studies, said: "There have been some specific
improvements; for example, some Member States have lowered their
blood alcohol limit for the legal limit for drink driving
at the moment the UK and Malta remain the only countries with
the highest legal limit that is above the recommended European
Commission limit."[70]
71. Prof Sheron thought that the Strategy
had been successful in increasing information and raising awareness,
its fourth priority: "The Strategy has done quite a bit to
do that, and the research projects funded by the Strategy, such
as the ALICE RAP project,[71]
have also contributed."[72]
72. Several witnesses criticised the failure
by the Strategy to achieve its goals in the fifth priority area,
the development of a common evidence base. Representatives of
the Government and the European spirits industry were disappointed
that not enough progress had been made with regard to collecting
comparable standardised data on alcohol consumption and alcohol-related
harm across the EU.[73]
Furthermore, the alcohol and advertising industries were highly
critical of EU-funded research conducted under the Strategy. We
consider both these issues in Chapter 9.
EU action on alcohol-related
harm since 2012
73. At the beginning of 2014, the ENVI Committee
of the European Parliament started work towards a resolution calling
on the European Commission to develop a new EU Alcohol Strategy.
The final text was expected to be adopted in the April Plenary
session of the European Parliament, but the EU Alcohol Strategy
resolution was not included in its final discussions. The ENVI
Committee last discussed the current state of play regarding the
EU Alcohol Strategy at its meeting on 29 January 2015.
74. In January 2014 a Joint Action on Reducing
Alcohol Related Harm (RARHA) was created within CNAPA in order
to "continue work on key priorities of the EU Alcohol Strategy".[74]
Over the course of three years, the Joint Action will focus on
three core work areas: providing comparable cross-country data
on levels and patterns of alcohol consumption and alcohol-related
harm (including third party harms), fostering consensus on good
practice regarding the setting of guidelines on low-risk drinking,
and facilitating the exchange of good practices among health authorities
by establishing a toolkit on using information and education to
reduce alcohol-related harm.
75. On 16 September 2014 CNAPA endorsed an Action
Plan on youth and heavy episodic drinking for the period 2014-16.[75]
The Action Plan identifies six areas for action including related
actions and operational objectives. It claims to do so as "part
of the continuing work under the EU Alcohol Strategy". The
Summary Report of the 15th Plenary Meeting of the EAHF confirms
this relationship, stating that the Action Plan "is not intended
to replace an EU strategy but rather builds upon and complements
some objectives of the existing Strategy."[76] Box
6: Objectives of the Action Plan on Youth and Heavy Episodic Drinking
· Reduce heavy episodic drinking (binge drinking)
· Reduce accessibility and availability of alcoholic beverages for youth
· Reduce exposure of youth to alcohol marketing and advertising
· Reduce harm from alcohol during pregnancy
· Ensure a healthy and safe environment for youth
· Support monitoring and increase research
|
76. CNAPA is currently carrying out a scoping
exercise for the Commission in order to inform its next steps.
In addition, the current Latvian Presidency has confirmed that
it will "follow the work of [CNAPA], and is in the process
of developing a scoping paper on the vision of future actions
to be taken in the area of an alcohol policy in the EU. The Presidency
will put in the effort required to bring the attention
of EU health ministers to issues regarding alcohol and nutrition."[77]
The current status of the 2006-12
Strategy
77. The terminal date of 2012 is given to the
Strategy in its final section: "the Commission
presents
a comprehensive strategy to reduce alcohol-related harm in Europe
until the end of 2012". This begs the question what the significance,
if any, is of the last words "until the end of 2012".
78. The wording of both the RARHA Joint Action
and the 2014-16 Action Plan seems to indicate that the EU Alcohol
Strategy has remained valid as a policy tool past its expiry date
of 2012. This is confirmed by the Summary Report of the 15th Plenary
Meeting of the EAHF on 6 November 2014, which states that "For
the time being, the existing goals and objectives of the alcohol
Strategy remain valid."[78]
79. This was also the view of many of our witnesses,
but not of several public health representatives, who thought
that the failure to renew the Strategy in 2012 meant that there
was currently a dangerous gap in EU alcohol policy. For example,
the Institute for Alcohol Studies regarded "the failure to
establish a renewed Strategy in 2012 as a significant setback
for achieving progress on reducing alcohol harm in Europe."[79]
Eurocare submitted that "The absence of a current EU Alcohol
Strategy means that there is no comprehensive policy framework
in existence at the EU level that can be compared to the WHO Global
Alcohol Strategy or WHO EU Alcohol Action Plan."[80]
80. Ms Willmott suggested that delays in
implementing a new strategy in 2012 may have been due to the pending
European elections, and that to remedy such difficulties a new
strategy "should cover the whole Parliament and slightly
beyond that in future so we have time to have a new strategy in
place."[81] She
further noted that, despite subsequent political agreement in
the European Parliament's ENVI Committee on the need for a new
strategy, the Commission seemed reluctant to move forward: "We
were very disappointed by the Commission's answer when we brought
representatives to the committee and asked them what is happening
to the alcohol Strategy. To be honest, they just prevaricated
and did not really give much of a clear answer."[82]
81. According to Ms Skar, in 2012 stakeholders
across all sectors were keen to see a new EU Alcohol Strategy
put into place: "Eurocare was not the only NGO that called
for it
Even industry was sending press releases calling
for the Commission to move forward. A number of Member States
were calling
I think the Commission was simply dragging
its feet or was not willing to do it."[83]
82. We think this is a likely explanation. Among
its many strategies the EU had a Drugs Strategy, which was the
subject of our report The EU Drugs Strategy.[84]
That Strategy too expired at the end of 2012. Drugs, unlike alcohol,
were then the responsibility of the Directorate-General for Justice,
and so subject to the Hague Programme for Justice and Home Affairs
from 2005-10, and then to its successor, the Stockholm Programme,
from 2010-15. That Programme, adopted by the European Council
in April 2010, stated:
"The Union Drugs Strategy (2005-2012) advocates
for a global, balanced approach, based on the simultaneous reduction
of supply and demand. This strategy will expire during the Stockholm
Programme. It must be renewed on the basis of a detailed evaluation
of the EU Drugs Action Plan for 2009-2012,[85]
carried out by the Commission with the support of the European
Monitoring Centre for Drugs and Drug Addiction and Europol."[86]
83. There is no doubt that those were the views
of the Commission, since these words were taken verbatim from
a Commission Communication of 10 June 2009.[87]
Yet when, for our inquiry into the EU Drugs Strategy, we took
evidence from Viviane Reding, then a Vice-President of the Commission
and the Commissioner for Justice,[88]
she described the Strategy to us as "a thing of the past"
and "a nice piece of literature". Later she said: "You
know strategy is wishful thinking".[89]
Despite those views, following an evaluation of the Drugs Strategy,
the Commission proposed and the Council endorsed on 7 December
2012 a new Drugs Strategy running from 2013-20.
84. Notwithstanding the similar evaluation of
the Alcohol Strategy, the Commission undertook no comparable initiative
for its renewal, and also refrained from issuing a clear statement
on its current status. Unfortunately we were unable to ask DG
SANCO to respond to these concerns. We invited Philippe Roux,
Head of Unit for Health Determinants, to attend an evidence session
in Brussels or, alternatively, to submit written comments to provide
us with the Commission's views on issues covered by our inquiry.
He declined both opportunities to comment on the record, referring
the Committee instead to the outdated 2012 evaluation report of
the Strategy as an illustration of the Commission's views on the
matter.
85. At the time of the Committee's request, DG
SANCO was preparing to welcome the new Commissioner for Health,
following the establishment of the new Commission in the autumn
of 2014. Since the Strategy had not been renewed two years earlier,
it was understandable that Mr Roux did not wish to commit
himself to any statements on the future of the Strategy. However,
the apathy with which the Commission seems to have greeted the
expiry of the previous Strategy has resulted in uncertainty over
its current status and on how best to proceed in the interim before
the Commission proposes a renewed, amended or entirely new strategyif
indeed this is its intention.
45 Council Conclusions of 5 June 2001 on a Community
strategy to reduce alcohol-related harm (OJ C 175, 20.6.2001,
p. 1): http://europa.eu/legislation_summaries/public_health/health_determinants_lifestyle/
c11564a_en.htm
[accessed 24 February 2015] Back
46
See Appendix 4. Back
47
European Commission, 'European Alcohol and Health Forum: More
information': http://ec.europa.eu/
health/alcohol/forum/forum_details/index_en.htm
[accessed 24 February 2015] Back
48
European Commission, 'Committee on National Alcohol Policy and
Action': http://ec.europa.eu/health/
alcohol/committee/index_en.htm
[accessed 24 February 2015] Back
49
European Commission, 'Alcohol Projects': http://ec.europa.eu/health/alcohol/projects/index_en.htm
[accessed 24 February 2015] Back
50
COWI-Milieu, Assessment of the added value of the EU strategy
to support Member States in reducing alcohol-related harm
(December 2012): http://ec.europa.eu/health/alcohol/docs/
report_assessment_eu_alcohol_strategy_2012_en.pdf
[accessed 24 February 2015].
In this report we refer to this document as "the 2012 evaluation". Back
51
Written evidence from the Advertising Association (EAS0015),
Association of Convenience Stores, (EAS0010) BBPA (EAS0013), spiritsEUROPE
(EAS0025) and UK Government Department of Health (EAS0019); Q14
(Crispin Acton), Q119 (Simon Spillane) Back
52
Q37 (Dr Evelyn Gillan) Back
53
Q228 Back
54
Q228 Back
55
Q188 Back
56
Q102 (Mariann Skar and Eric Carlin), Q129 (Simon
Spillane) Back
57
SMART targets are those which are specific, measurable, attainable,
realistic and timely. Back
58
Q102 Back
59
Q2 Back
60
Q2 Back
61
Q102 Back
62
Q153 Back
63
Written evidence from spiritsEUROPE (EAS0025) Back
64
For example Q53 (Guy Parker) and Q202 (Henry Ashworth) Back
65
Q100 Back
66
Q187 (Miles Beale), written evidence from the Advertising
Association (EAS0015) Back
67
Q202 Back
68
Q14 Back
69
Q228 (Jane Ellison MP) Back
70
Q34. Since Ms Brown gave evidence, on 5 December 2014
Scotland reduced its drink driving alcohol level to 50mg of alcohol
per 100ml of blood. Back
71
ALICE RAP is a European research project, co-financed by the
European Commission, which started in April 2011 and aims to stimulate
a broad and productive debate on science-based policy approaches
to addictions. Back
72
Q35 Back
73
Q23 (Crispin Acton), Q130 (Paul Skehan) Back
74
RARHA, 'Background and Purpose': http://www.rarha.eu/About/BackgroundPurpose/Pages/default.aspx
[accessed 24 February 2015] Back
75
CNAPA, Action Plan on Youth Drinking and on Heavy Episodic
Drinking (Binge Drinking) (2014-16) (September 2014): http://ec.europa.eu/health/alcohol/docs/2014_2016_actionplan_youthdrinking_en.pdf
[accessed 24 February 2015] Back
76
European Alcohol and Health Forum, 15th Plenary Meeting, summary
report (6 November 2014): http://ec.europa.eu/health/alcohol/docs/ev_20141106_sumrep_en.pdf
[accessed 24 February 2015] Back
77
The programme of the Latvian Presidency of the Council of the
European Union: https://eu2015.lv/
images/PRES_prog_2015_EN-final.pdf
[accessed 24 February 2015].
See also written statement by Jane Ellison MP: HC Deb, 9
December 2014, col 33WS. Back
78
European Alcohol and Health Forum, 15th Plenary Meeting, summary
report (6 November 2014): http://ec.europa.eu/health/alcohol/docs/ev_20141106_sumrep_en.pdf
[accessed 24 February 2015] Back
79
Written evidence from Eurocare (EAS0006), Alcohol Health Alliance
UK (EAS0012), Balance (EAS0017), Institute for Alcohol Studies
(EAS0002), and SHAAP (EAS0001) Back
80
Written evidence from Eurocare (EAS0006) Back
81
Q155 (Glenis Willmott MEP) Back
82
Q155 (Glenis Willmott MEP) Back
83
Q105 (Mariann Skar) Back
84
European Union Committee, The EU Drugs Strategy (26th Report,
Session 2010-12, HL Paper 270) Back
85
The EU Drugs Strategy 2005-12 included two Action Plans, the second
running from 2009-12. Back
86
OJ C 115, 4 May 2010, paragraph 4.4.6 Back
87
Communication from the Commission to the European Parliament and
the Council on an area of freedom, security and Justice serving
the citizen, COM(2009)262 final, paragraph 4.3.1 Back
88
Now MEP Back
89
Oral evidence taken on 28 November 2011 (Session 2010-12), QQ209, 227 Back
|